Risk factors and outcomes of anxiety symptom trajectories in type 2 diabetes: the Fremantle Diabetes Study Phase II.

S R Whitworth David G BruceS E StarksteinT M E DavisTimothy Charles Skinner Wendy A Davis Romola S Bucks

Published in: Diabetic medicine : a journal of the British Diabetic Association (2020)

A subgroup of individuals with type 2 diabetes are at risk of persistently elevated anxiety symptoms. Routine monitoring of the severity of psychological symptoms over time in this population should facilitate earlier and more intensive mood management.

Keyphrases

sleep quality
type diabetes
phase ii
depressive symptoms
glycemic control
risk factors
clinical trial
open label
cardiovascular disease
phase iii
physical activity
bipolar disorder
insulin resistance
placebo controlled
study protocol